Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

Single-dose tafenoquine to prevent relapse of Plasmodium vivax malaria

<p><strong>Background</strong> Treatment of Plasmodium vivax malaria requires the clearing of asexual parasites, but relapse can be prevented only if dormant hypnozoites are cleared from the liver (a treatment termed “radical cure”). Tafenoquine is a single-dose 8-aminoquinoline th...

Полное описание

Библиографические подробности
Главные авторы:	Lacerda, MVG, Llanos-Cuentas, A, Krudsood, S, Lon, C, Saunders, DL, Mohammed, R, Yilma, D, Batista Pereira, D, Espino, FEJ, Mia, RZ, Chuquiyauri, R, Val, F, Casapía, M, Monteiro, WM, Brito, MAM, Costa, MRF, Buathong, N, Noedl, H, Diro, E, Getie, S, Wubie, KM, Abdissa, A, Zeynudin, A, Abebe, C, Tada, MS, Brand, F, Beck, H-P, Angus, B, Duparc, S, Kleim, J-P, Kellam, LM, Rousell, VM, Jones, SW, Hardaker, E, Mohamed, K, Clover, DD, Fletcher, K, Breton, JJ, Ugwuegbulam, CO, Green, JA, Koh, GCKW
Формат:	Journal article
Язык:	English
Опубликовано:	Massachusetts Medical Society 2019

Схожие документы

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
по: Llanos-Cuentas, A, и др.
Опубликовано: (2019)

Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria
по: St Jean, PL, и др.
Опубликовано: (2020)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis
по: Watson, JA, и др.
Опубликовано: (2022)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis'
по: Watson, JA, и др.
Опубликовано: (2024)

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
по: Mark M Fukuda, и др.
Опубликовано: (2017-01-01)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
по: Stephan Duparc, и др.
Опубликовано: (2020-03-01)

Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD Mahidol variant) versus G6PD-normal volunteers
по: Rueangweerayut, R, и др.
Опубликовано: (2017)

Tafenoquine — a radical improvement?
по: White, N
Опубликовано: (2019)

The antimalarial activity of tafenoquine in falciparum malaria
по: White, NJ
Опубликовано: (2023)

Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria
по: Raman Sharma, и др.
Опубликовано: (2024-05-01)

Tafenoquine for travelers' malaria: evidence, rationale and recommendations
по: Baird, J
Опубликовано: (2018)

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
по: Watson, JA, и др.
Опубликовано: (2021)

Tafenoquine for children: a step towards implementation
по: Commons, RJ, и др.
Опубликовано: (2021)

Repurposing of the antimalarial agent tafenoquine to combat MRSA
по: Pengfei She, и др.
Опубликовано: (2023-12-01)

Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
по: Geoffrey W. Birrell, и др.
Опубликовано: (2022-11-01)

Tafenoquine and G6PD: a primer for clinicians
по: Chu, CS, и др.
Опубликовано: (2019)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
по: Watson, J, и др.
Опубликовано: (2019)

Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
по: Luisa Oliveira Santos, и др.
Опубликовано: (2024-08-01)

The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis
по: James A Watson, и др.
Опубликовано: (2022-12-01)

Single loading-dose tafenoquine for malaria chemoprophylaxis during brief travel?
по: Baird, JK
Опубликовано: (2021)

Response to comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
по: James A Watson, и др.
Опубликовано: (2024-02-01)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection.
по: Römsing, S, и др.
Опубликовано: (2011)

Determination of tafenoquine in dried blood spots and plasma using LC and fluorescence detection
по: Romsing, S, и др.
Опубликовано: (2011)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria
по: Watson, J, и др.
Опубликовано: (2018)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
по: James Watson, и др.
Опубликовано: (2018-04-01)

Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency
по: Commons, RJ, и др.
Опубликовано: (2020)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
по: Ebstie YA, и др.
Опубликовано: (2016-07-01)

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?
по: Amit Sharma, и др.
Опубликовано: (2021-02-01)

Activities of artesunate-based combinations and tafenoquine against Babesia bovis in vitro and Babesia microti in vivo
по: Leonardo J. M. Carvalho, и др.
Опубликовано: (2020-07-01)

Extended blood stage sensitivity profiles of Plasmodium cynomolgi to doxycycline and tafenoquine, as a model for Plasmodium vivax
по: Christensen, Peter, и др.
Опубликовано: (2024)

Radical curative efficacy of tafenoquine combination regimens in <it>Plasmodium cynomolgi</it>-infected Rhesus monkeys (<it>Macaca mulatta</it>)
по: Kenworthy David, и др.
Опубликовано: (2011-07-01)

Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum
по: Karen Kemirembe, и др.
Опубликовано: (2017-08-01)

Enantiomeric resolution of primaquine, quinacrine and tafenoquine antibacterial medicines using ristocetin macrocyclic glycopeptide antibiotics CSP
по: Zeid A. ALOthman, и др.
Опубликовано: (2020-01-01)

Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'
по: Raman Sharma, и др.
Опубликовано: (2024-02-01)

Phytochemical Screening and Antimicrobial Activity Evaluation of Selected Medicinal Plants in Ethiopia
по: Dubale S, и др.
Опубликовано: (2023-02-01)

A randomized, double-blind, placebo-controlled, dose-ranging trial of tafenoquine for weekly prophylaxis against Plasmodium falciparum.
по: Hale, B, и др.
Опубликовано: (2003)

Efficacy Evaluation of 10-Hydroxy Chondrofoline and Tafenoquine against <i>Leishmania tropica</i> (HTD<sub>7</sub>)
по: Sayyed Ibrahim Shah, и др.
Опубликовано: (2022-08-01)

Failure of an Approximately Six Week Course of Tafenoquine to Completely Eradicate <i>Babesia microti</i> Infection in an Immunocompromised Patient
по: Prithiv J. Prasad, и др.
Опубликовано: (2022-09-01)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
по: Hounkpatin AB, и др.
Опубликовано: (2019-03-01)

The blood schizonticidal activity of tafenoquine makes an essential contribution to its prophylactic efficacy in nonimmune subjects at the intended dose (200 mg)
по: Geoffrey Dow, и др.
Опубликовано: (2017-05-01)